The National Institutes of Health (NIH), through its HEAL Initiative, is offering this Small Business Innovation Research (SBIR) grant to address the national opioid public health crisis. This grant is for the purpose of accelerating scientific solutions by supporting the development of therapies and technologies aimed at enhanced pain management. Specifically, it seeks applications for new non-addictive medications and devices, and objective pain measurement tools. Furthermore, the initiative is interested in novel screening tools and models focused on pain, facilitating the development of advanced pain therapies. This funding aims to foster innovative approaches to improve pain treatment effectively.
Opportunity ID: 343550
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-NS-23-006 |
| Funding Opportunity Title: | HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.213 — Research and Training in Complementary and Integrative Health |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Sep 15, 2022 |
| Last Updated Date: | Sep 15, 2022 |
| Original Closing Date for Applications: | Apr 04, 2025 |
| Current Closing Date for Applications: | Apr 04, 2025 |
| Archive Date: | May 10, 2025 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Innovation Research (SBIR) program. This FOA is focused on applications directed at improving pain treatment, including the development of new non-addictive medications and devices and objective pain measurement. In addition, NIH is interested in new screening tools and models focused specifically on pain and development of pain therapies. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-23-006.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00276818 | Dec 04, 2022 | Jan 24, 2023 | View | |
| FORMS-H | Use for due dates on or before January 24, 2025 | PKG00278401 | Dec 04, 2022 | Jan 24, 2025 | View | |
| FORMS-I | Use for due dates on or after January 25, 2025 | PKG00289127 | Nov 26, 2024 | Apr 04, 2025 | View |
Package 1
Mandatory forms
343550 RR_SF424_5_0-5.0.pdf
343550 PHS398_CoverPageSupplement_5_0-5.0.pdf
343550 RR_OtherProjectInfo_1_4-1.4.pdf
343550 PerformanceSite_4_0-4.0.pdf
343550 RR_KeyPersonExpanded_4_0-4.0.pdf
343550 RR_Budget_3_0-3.0.pdf
343550 PHS398_ResearchPlan_4_0-4.0.pdf
343550 SBIR_STTR_Information_3_0-3.0.pdf
343550 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
343550 RR_SubawardBudget30_3_0-3.0.pdf
343550 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
343550 RR_SF424_5_0-5.0.pdf
343550 PHS398_CoverPageSupplement_5_0-5.0.pdf
343550 RR_OtherProjectInfo_1_4-1.4.pdf
343550 PerformanceSite_4_0-4.0.pdf
343550 RR_KeyPersonExpanded_4_0-4.0.pdf
343550 RR_Budget_3_0-3.0.pdf
343550 PHS398_ResearchPlan_5_0-5.0.pdf
343550 SBIR_STTR_Information_3_0-3.0.pdf
343550 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
343550 RR_SubawardBudget30_3_0-3.0.pdf
343550 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
343550 RR_SF424_5_0-5.0.pdf
343550 PHS398_CoverPageSupplement_5_0-5.0.pdf
343550 RR_OtherProjectInfo_1_4-1.4.pdf
343550 PerformanceSite_4_0-4.0.pdf
343550 RR_KeyPersonExpanded_4_0-4.0.pdf
343550 RR_Budget_3_0-3.0.pdf
343550 PHS398_ResearchPlan_5_0-5.0.pdf
343550 SBIR_STTR_Information_3_0-3.0.pdf
343550 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
343550 RR_SubawardBudget30_3_0-3.0.pdf
343550 PHS_AssignmentRequestForm_4_0-4.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
